Improvement of the oral bioavailability of coenzyme Q10 with lecithin nanocapsules

Journal of Nanoscience and Nanotechnology

Volumn 13, Issue 1, 2013, Pages 706-710

  Zhou, Huafeng ^a,b   Zhang, Jing ^b   Long, Yingfang ^b   Liu, Guoqing ^a   Duan, Mingxing ^b   Xia, Qiang ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

Bioavailability; Coenzyme Q10; Freeze fracture transmission electron microscopy; Lecithin nanocapsules

Indexed keywords

BIOAVAILABILITY; COENZYME Q10; FREEZE-FRACTURE TRANSMISSION ELECTRON MICROSCOPIES; HIGH PRESSURE HOMOGENIZATION; MALVERN INSTRUMENTS; ORAL BIOAVAILABILITIES; RELATIVE BIOAVAILABILITY; SUPERCOOLED STATE;

DIFFERENTIAL SCANNING CALORIMETRY; FRACTURE; LECITHIN; NANOCAPSULES; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

BIOCHEMISTRY;

DRUG DERIVATIVE; NANOCAPSULE; PHOSPHATIDYLCHOLINE; UBIDECARENONE; UBIQUINONE;

ANIMAL; ARTICLE; BIOAVAILABILITY; CHEMISTRY; MATERIALS TESTING; METABOLISM; MOUSE; MOUTH;

ANIMALS; BIOLOGICAL AVAILABILITY; LECITHINS; MATERIALS TESTING; MICE; MOUTH; NANOCAPSULES; UBIQUINONE;

MLCS; MLOWN;

EID: 84876278347     PISSN: 15334880     EISSN: 15334899     Source Type: Journal    
DOI: 10.1166/jnn.2013.7089     Document Type: Article

References (38)

1. F. L. Crane, J. Am. Coll. Nutr. 20, 591 (2001).
2. U. Hoppe, J. Bergemann, W. Diembeck, J. Ennen, S. Gohla, and I. Harris, Biofactors 9, 371 (1999).
3. R. Montero, J. A. Sánchez-Alcázar, P. Briones, A. Navarro-Sastre, E. Gallardo, and B. Bornstein, Clin. Biochem. 42, 742 (2005).
4. R. Stocker, C. Pollicino, C. A. Gay, P. Nestel, D. Colquhoun, and M. Whiting, Atherosclerosis 187, 198 (2006).
5. S. Pepe, S. F. Marasco, S. J. Haas, F. L. Sheeran, H. Krum, and F. L. Rosenfeldt, Mitochondrion Suppl. 7, s154 (2007).
6. U. Ullmann, J. Metzner, C. Schulz, J. Perkins, and B. Leuenberger, J. Med. Food 8, 397 (2005).
7. J. Kaikkonen, K. Nyyssonen, E. Porkkala-Sarataho, H. E. Poulsen, T. Metsa-Ketela, M. Hayn, R. Salonen, and J. T. Salonen, Free Radic. Biol. Med. 22, 1195 (1997).
8. F. Rosenfeldt, S. Marasco, W. Lyon, M. Wowk, F. Sheeran, and M. Bailey, J. Thorac. Cardiov. Sur. 129, 25 (2005).
9. J. Fu, D. X. Wang, T. Wang, W. J. Yang, Y. Deng, H. Wang, S. G. Jin, and N. Y. He, J. Biomed. Nanotechnol. 6, 725 (2010).
10. W. J. Yang, J. Fu, T. Wang, and N. Y. He, J. Biomed. Nanotechnol. 5, 591 (2009).
11. M. C. Terence, S. B. Faldini, L. F. Miranda, A. H. Munhoz, and P. J. Castro, J. Biomed. Nanotechnol. 7, 446 (2011).
12. V. Pokharkar, D. Bhumkar, K. Suresh, Y. Shinde, S. Gairola, and S. S. Jadhav, J. Biomed. Nanotechnol. 7, 57 (2011).
13. A. K. Verma, R. P. Pandey, A. Chanchal, and P. Sharma, J. Biomed. Nanotechnol. 7, 63 (2011).
14. S. Rai, R. Paliwal, and S. P. Vyas, J. Biomed. Nanotechnol. 7, 121 (2011).
15. S. Malathi and S. Balasubramanian, J. Biomed. Nanotechnol. 7, 150 (2011).
16. Y. Yue, H. F. Zhou, G. L. Liu, Y. Li, Z. M. Yan, and M. X. Duan, Int. J. Pharm. 392, 57 (2010).
17. C. J. H. Porter, N. L. Trevaskis, and W. N. Charman, Nat. Rev. Drug Discov. 6, 231 (2007).
18. D. D. Ankola, R. M. Wadsworth, and M. N. V. Ravi Kumar, J. Biomed. Nanotechnol. 7, 300 (2011).
19. R. Paliwal, S. Rai, and S. P. Vyas, J. Biomed. Nanotechnol. 7, 130 (2011).
20. B. E. Rabinow, Nat. Rev. Drug Discov. 3, 785 (2004).
21. S. Chakraborty, D. Shukla, B. Mishra, and S. Singh, Eur. J. Pharm. Biopharm. 73, 1 (2009).
22. P. Balakrishnan, B. J. Lee, D. H. Oh, J. O. Kim, Y. I. Lee, and D. D. Kim, Int. J. Pharm. 374, 66 (2009).
23. T. R. Kommuru, B. Gurley, M. A. Khan, and I. K. Reddy, Int. J. Pharm. 212, 233 (2001).
24. N. T. Huynh, C. Passirani, P. Saulnier, and J. P. Benoit, Int. J. Pharm. 379, 201 (2009).
25. S. Peltier, J. M. Oger, F. Lagarce, W. Couet, and J. P. Benoit, Pharm. Res. 23, 1243 (2006).
26. C. Freitas and R. H. Müller, Int. J. Pharm. 168, 221 (1998).
27. H. F. Zhou, Y. Yue, G. L. Liu, Y. Li, J. Zhang, Z. M. Yan, and M. X. Duan, Nanoscale Res. Lett. 5, 1561 (2010).
28. K. Westen and H. Bunjes, Int. J. Pharm. 115, 129 (1995).
29. S. Wissing, R. H. Müller, L. Manthei, and C. Mayer, Pharm. Res. 21, 400 (2004).
30. E. Zimmermann, E. B. Souto, and R. H. Muller, Pharmazie 60, 508 (2005).
31. J. Kuntsche, M. H. J. Koch, A. Fahr, and H. Bunjes, Eur. J. Pharm. Sci. 38, 238 (2009).
32. J. Kuntsche and H. Bunjes, Eur. J. Pharm. Biopharm. 67, 612 (2007).
33. R. K. Chopra, R. Goldman, S. T. Sinatra, and H. N. Bhagavan, Int. J. Vitam. Nutr. Res. 68, 109 (1998).
34. M. V. Miles, Mitochondrion Suppl. 7, S72 (2007).
35. N. L. Trevaskis, W. N. Charman, and C. J. H. Porter, Adv. Drug Deliver. Rev. 60, 702 (2008).
36. C. J. H. Porter, C. W. Pouton, J. F. Cuine, and W. N. Charman, Adv. Drug Deliver. Rev. 60, 673 (2008).
37. E. S. Swenson and W. J. Curatolo, Adv. Drug Deliver. Rev. 8, 39 (1992).
38. K. Sachs-Barrable, S. D. Lee, E. K. Wasan, S. J. Thornton, and K. M. Wasan, Adv. Drug Deliver. Rev. 60, 692 (2008).